| HOME | ABOUT US | PRODUCTS | TECHNOLOGY | INVESTOR RELATIONS | CONTACT US |
INVESTOR RELATIONSInnovative Biosystems Inc. aims to become the premier global provider of affordable, convenient, and easy to use point-of-care testing solutions.
|
||||
|
Our Market | |||
| IBI will capitalize on the large market potential of the human POCT market (approximately $15 billion worldwide) and veterinary market (approximately $1 billion) with key offerings like the EZ-INR, MAX-Mini, and other supporting POCT products. | ||||
| Our Strategy | ||||
| By cooperating with pre-existing distributors and medical suppliers around the globe, IBI will tap into key user demographics for both the human POCT and veterinary markets. | ||||
| Recent News & Events | ||||
• AACC 2014, Chicago, IL: Come visit us at Booth #2343 and see the newest developments from IBI! • The EZ-INR Coagulation Test Device is now CE Marked! |
||||
| Contact us for more information | ||||
Innovative BioSystems • 2100 South Reservoir Street • Pomona, CA 91766
Phone: (909) 627-2727 • (888) 838-2435 • Fax: (909) 465-1616 • sales@ibiosystems.com
Phone: (909) 627-2727 • (888) 838-2435 • Fax: (909) 465-1616 • sales@ibiosystems.com